Chemical name: [1,1'-Biphenyl]-4-amine

Final regulatory action has been taken for the category: Industrial

Final regulatory action: The chemical is Severely Restricted

Use or uses prohibited by the final regulatory action:

Such substances and preparations may not be sold to the general public. Without prejudice to the application of other EU provisions on the classification, packaging and labelling of dangerous substance and preparations, the packaging of such preparations shall be legible and indelibly marked as follows: "Restricted to professional users."

Use or uses that remain allowed:

All other uses not listed above.

The final regulatory action was based on a risk or hazard evaluation: Yes

Summary of the final regulatory action:

Such substances and preparations shall not be sold to the general public. Without prejudice to the application of other EU provisions on the classification, packaging and labelling of dangerous substance and preparations, the packaging of such preparations shall be legible and indelibly marked as follows: "Restricted to professional users."

The reasons for the final regulatory action were relevant to: Human health

Summary of known hazards and risks to human health:

The compound is similar to benzidine regarding the health effects. This compound affects the blood and may damage the liver and kidneys. The compound has been shown to be carcinogenic. This compound is taken up through the skin. In addition to burning, delayed symptoms can occur, such as nausea, dizziness, headaache, breathlessness, cyanosis, cramps, drowsiness and even effects on the heart and loss of consciousness depending on degree of exposure. Textiles and leather products containing azo dyes can release aryl amines that may cause cancer.

Date of entry into force of the final regulatory action: 01/01/2001